Canadian Journal of Cardiology

Transfemoral Lotus Valve Implantation for Treatment of Postendocarditis Stentless Prosthesis Degeneration With Pure Aortic Regurgitation

      An 83-year-old man with a previous history of aortic valve replacement (27-mm stentless bioprosthesis) and root replacement in 2001 presented with fever and symptoms of worsening heart failure. Transesophageal echocardiography revealed severe aortic regurgitation (AR) resulting from prosthetic cusp perforation, and because blood culture results were positive for methicillin-sensitive Staphylococcus aureus, a diagnosis of prosthetic endocarditis was made. After prolonged antibiotic treatment, fluorodeoxyglucose position emission tomography excluded active endocarditis. In view of his comorbidities (stage III chronic kidney disease) and increased surgical risk, given his previous heart surgery (Society of Thoracic Surgeons score, 5.8%; logistic EuroSCORE, 17.09%), it was decided that he would be best treated with transcatheter aortic valve implantation (TAVI).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wöhrle J.
        • Rodewald C.
        • Rottbauer W.
        Transfemoral aortic valve implantation in pure native aortic valve insufficiency using the repositionable and retrievable lotus valve.
        Catheter Cardiovasc Interv. 2016; 87: 993-995
      1. Nerla R, Cremonesi A, Castriota F. Successful percutaneous paravalvular leak closure followed by transfemoral aortic lotus valve-in-valve implantation in a degenerated surgical bioprosthesis [e-pub ahead of print]. Catheter Cardiovasc Interv doi:10.1002/ccd.26552, accessed May 3, 2016.